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1. Introduction 
The World Health Organization subdivides the histologic appearance of OS into central and 
surface tumors, and recognises a number of subtypes within each group [1]. OS frequently 
originate in the metaphysis of the distal femur, proximal tibia and proximal humerus. OSs 
are subdivided into the classic form (75%) and osteosarcoma variants (25%) [2, 3 & 4]. The 
variants form a heterogeneous group with a range of different imaging and behavioral 
features (Figures 1-7).  
The long-term survival has improved thanks to more accurate diagnosis and better staging 
by imaging.  The classic OS grows in a radial manner, which invades the bony cortex 
forming a ball-like area of new bone formation/destruction that compresses the 
surrounding soft tissues/muscles effectively forming a pseudocapsule termed as the 
“reactive zone.” Satellite nodules invade the reactive zone. To ensure effective surgical 
therapy the entire abnormal bone including the reactive zone containing the satellites is 
resected with wide surgical margins. OS may metastasize regionally or systemically. The 
presence of metastasis worsens the prognosis dramatically. Tumor nodules that grow 
outside the reactive zone but within the same bone or across a neighbouring joint are called 
“skip lesions” and represent regional metastases. Lungs are the commonest site of systemic 
metastases. The skeleton forms the second most common site of metastatic disease but 
generally occur after pulmonary metastases.  
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Fig. 1. The illustration shows a radiograph of a right ankle in a 12-year old. He presented 
with vague ankle pain and a slight limp. The radiograph shows mixed lytic and 
osteosclerotic lower tibial metaphyseal lesion (yellow arrow). Note the subtle laminated 
periosteal reaction (red arrow). A surgical biopsy confirmed a classical osteogenic sarcoma. 
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Fig. 2. Radiograph of the lower femur shows a sclerotic lesion of the lower femoral 
metaphysis. An associated exuberant “sun ray” periosteal reaction (red arrows) is seen. A 
biopsy revealed an osteosarcoma. Note the area of sclerosis is extending into the epiphysis. 
 
Fig. 3. The figure show radiographs from two different patients depicting a markedly 
osteosclerotic lesion of the upper tibia (A) and radiograph (B) from a more skeletally mature 
case that shows an entirely osteolytic lesions. Both lesions proved osteosarcomas on biopsy. 
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Fig. 4. The figure shows another mixed lytic and sclerotic metaphyseal tumor (yellow 
arrow). The tumor is crossing the epiphyseal line. Both ‘sun ray’ and onionskin periosteal 
reactions (red arrows) are shown.     
 
Fig. 5. Image A shows, biopsy proved osteosarcoma involving the whole shaft of the 
humerus. Image B depicts multiple lung metastases from the same patient. Note bilateral 
pleural effusions due to histologically proved pleural metastatic disease. 
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Fig. 6. AP and lateral radiographs of the lower femur shows a biopsy proved diaphyseal 
variant of OS. Note the mixed lytic/sclerotic lesion (black arrow) and the laminated 
periosteal new bone formation (yellow arrow).  
2. Discussion  
OS affects the age groups between 15–25 years in over 75% of cases with a gender ratio M: 
F=1.5:1. OS is uncommon in patients younger than 6 years or older than 60 years. OS in the 
older age group are usually secondary to Paget's disease, radiation or dedifferentiated 
chondrosarcomas. By far the highest percentage of OS (80% to 90%) occurs in the long 
tubular bones. The axial skeleton is rarely involved. Femur, tibia and humerus account for 
about 85% of extremity tumors. OS usually originate in the metaphysis of the long bones; 
tumors originating in the diaphysis and the epiphysis are rare Figures (1-7) [5 & 6].  
The cause is not known but ionising radiation is implicated in 2% of OSs [7]. A genetic 
relationship exists with hereditary retinoblastoma. In patients with retinoblastoma, OS 
occurs 500 times more often than in the general population [8]. Three to four per cent 
children suffering from OS carry an inherent germline mutation in p539. The majority of 
children with germline p53 mutations have a family history suggestive of Li-Fraumeni 
syndrome Rarely OS is associated with single or multiple osteochondroma, solitary 
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enchondroma or enchondromatosis, multiple hereditary exostoses, fibrous dysplasia, 
chronic osteomyelitis, sites of bone infarcts, sites of metallic prostheses and sites of previous 
internal fixation. Ionizing radiation is a well-documented etiologic factor. OS is also 
associated with the use of intravenous radium and Thorotrast and exposure to alkylating 
agents independent of the administration of radiotherapy (Figures 8-16) [9]. 
 
Fig. 7. Image A and B shows radiographs of the lower femur in two different patients. Both 
represent variants of OS. Image A shows a classic OS originating at the metaphysis and 
invading the diaphysis. Image B is from 18-year old female shows a tumor based at the 
lower femoral diaphysis sparing the metaphysis. Note the exuberant periosteal reaction. The 
diagnosis of image B was parosteal OS.  
Patients typically present with pain and swelling, localized enlargement of the extremity 
and, occasionally, a pathologic fracture. Most patients have localized disease at presentation. 
Diagnosis and treatment of OS requires a multidisciplinary approach involving the primary 
health care physician, radiologist, pathologist, orthopedic surgeon/oncologist, and the 
medical oncologist. Imaging is crucial to early diagnosis. Imaging also can predict prognosis 
and allows separation from other focal bone pathology. Conventional radiography is 
usually the primary imaging used which often provides a clue to the diagnosis and often is a 
guide as to which modality should follow. Once the issue of an OS is raised, MRI is the 
critical next step in the local staging and the associated soft tissue involvement. CT scanning 
is less sensitive than MRI in local staging but is essential in depicting systemic metastases 
specifically to the lungs. Histologic confirmation is essential, and CT is often used as a guide 
to obtain tumor tissue. Conventional radiography generally depicts a combination of lytic 
and sclerotic areas within the tumor but purely lytic or sclerotic lesions may occur. The 
tumor appears moth eaten, with ill-defined margins, and may appear permeative with 
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several small cortical erosions. The tumor near joints is often difficult to distinguish from 
joint effusions. Periosteal new bone formation usually occurs once the cortex is breached. 
Periosteal new bone formation may take a variety of shapes and forms including a Codman 
triangle, an onionskin appearance or hair on end/ and sunburst reactions, all indicate an 
aggressive process. Other imaging studies that contribute to the diagnosis and management 
include radionuclide studies, PET/CT and US. PET/CT holds a promise. Presently 
angiography is rarely used in the diagnosis of OSs except for specific indications. Bone OSs 
whatever the type are initially imaged by conventional radiography. Radiographs of the 
involved bone are obtained in various planes and often a chest radiograph is obtained in the 
same sitting. Once the diagnosis is suspected, MRI forms the next imaging modality of 
choice to assess the extent of the tumor distribution within the bone and associated soft 
tissue component if any. If MRI is not available, CT provides the same information though is 
not as sensitive. Nevertheless, CT is an essential part of a staging procedure especially in the 
staging of pulmonary metastases. Histological opinion is always required because of 
radiological mimics of OSs (Figure 17). Biopsy should always be performed before a base 
line MRI is obtained.  
The various modalities are discussed in detail, and examples of different imaging are shown. 
2.1 Stages of osteosarcoma 
Staging of OSs is surgical based on Musculoskeletal Tumour Society staging system [10]:  
Tumor grade (I = low grade; II = high grade);  
Tumor extension (A = intraosseous involvement only; B = intra- and extraossseous 
extension);  
Presence of distant metastases (III)  
Nevertheless, imaging is required for correct staging including an isotope bone scan to rule 
out bone metastases and a chest radiograph and CT to rule out pulmonary metastases.  
Differential diagnosis of OS includes many benign and malignant lesions and soft tissue 
tumors adjacent to bones particularly long tubular bones. Imaging studies alone, however, 
may be sometimes confusing and histological opinion is always required. Osteolytic 
osteosarcoma may mimic malignant fibrous histiocytoma, fibrosarcoma or giant cell tumors. 
The diaphyseal variant of OS may resemble Ewing's sarcoma or lymphoma [11].  
Technetium-99m (99m Tc) methylene diphosphonate (MDP) radionuclide bone scans are 
extremely sensitive but has a low specificity for OS. Nevertheless, MDP scans are useful in 
depicting multifocal bone disease.  
Other imaging studies that contribute to the diagnosis and management include 
radionuclide studies, PET/CT and ultrasound. PET/CT holds a promise. Angiography is no 
longer used in the diagnosis of osteosarcomas.  
Although ultrasonography (US) is not considered when staging OS but it is a valuable 
modality in tissue sampling. US is also useful in patients with prosthetic implants in the 
detection of early local recurrence as MRI and CT may not be suitable, because of the artifact 
produced by the metal on CT scans or MRIs. 
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3. Conventional radiograph  
Conventional radiography is a non-invasive, affordable and widely available means that 
often provides a clue to the initial diagnosis, aggressiveness of the tumor and hence 
prognosis and provides a summary differential diagnosis. It can evaluate the effects of 
chemotherapy and diagnose lung metastases. In a suspected bone lesion, conventional 
radiographs are usually the initial imaging procedure. Conventional radiography may 
confirm a bony lesion, suggest diagnosis and guide further imaging. The anatomical 
location of the bone lesion the age of the patient and the clinical presentation help to 
formulate the list of differential diagnosis.  
In a review of 347 patients with extremity OS plain-film radiographic patterns of American Joint 
Committee on Cancer (AJCC) stage II OA were analysed and were found to be related with 
clinicopathological features. The study concluded that this finding has a potential use to 
provide valuable information for treatment decision-making in high-grade extremity OS [12].  
OS present with a variety of radiographic findings. Most OSs presents as a combination of 
osteolytic and osteosclerotic areas but lesions may be entirely lytic or sclerotic. Most OSs 
appears aggressive tumors with a moth eaten appearance and indistinct edges. Some OSs 
appears permeative, associated with multiple small cortical holes. Periosteal new bone 
formation surrounding the tumor is a common occurrence and occurs when the tumor 
breaks through the cortex. A Codman triangle is created when a triangular area of new 
subperiosteal bone formation raises the periosteum away from the bone. The main causes 
for this sign are OS, Ewing's sarcoma, and a subperiosteal abscess. Other types of periosteal 
reactions are multilaminated (“onionskin”), spiculated, and sunburst appearance (“hair on 
end”), all of which represent an aggressive process. Extension of the tumor beyond the bone 
into the surrounding soft tissues is common. As most OSs are near joints, differentiation of 
soft tissue extension may sometimes be difficult to distinguish from a joint effusion on 
radiography. ‘Cloudlike’ areas of sclerosis, resulting from malignant osteoid production and 
calcification, may be seen within the mass. Lung metastases are depicted as cannon ball 
lesions, which may calcify/ossify (Figures 1-7).  
Following chemotherapy, OSs becomes well defined often with a surrounding ‘capsule’. 
Atypical features in OS present diagnostic problems. Most OSs present late with aggressive 
features highly suggestive of OSs. However, early detection may cause diagnostic issues and 
tumors may be mistaken for benign lesions [13]. In these circumstances cross sectional 
imaging may indicate aggressive features suggestive of OS [14]. Rarely an expanding type of 
tumor may be, confined to the intramedullary cavity with no apparent aggressive features. 
Osteosclerotic OS confined to the intramedullary cavity have been confused with avascular 
necrosis [14, 15]. An OS may resemble an osteoblastoma or osteoid osteoma as a lytic defect 
with calcification or ossification within the defect and surrounded by sclerosis [14, 16].  
Intracortical OS is a rare variant, which, is contained within the cortex. Radiographs may 
indicate a fibrous cortical defect or a Brodie’s abscess. A CT scan depicts the tumor in an 
intra-cortical location [14, 17].  
A subchondral OS originates in the subchondral position extending across the epiphyseal 
plate into the metaphysis. This variant may resemble a giant cell tumor or a 
chondrosarcoma. These variants may be entirely lytic or sclerotic. The sclerotic type has a 
more malignant look [14, 18].  
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Diaphyseal OS located in the diaphysis are radiologically similar to classical OS. Rarely, 
diaphyseal OS may have a more sclerotic appearance resembling a benign process. A lytic tumor 
with or without multilaminated periosteal reaction may resemble Ewing’s sarcoma [14, 19].  
Cavarial OS are a rare variant that comprise less than 2% of all OSs [20]. The radiographic 
appearance is similar to classic OS. Lytic appearance is more common, but periosteal 
reaction is rare but a sclerotic hair on end appearance may indicate a poor prognosis. Most 
calvarial OS occur in young adults but a secondary type of OS occurs in the fifth decade or 
beyond and usually is associated with Paget’s disease and radiation therapy [14].  
Osteosarcoma of the calcaneus occurs in less than 1% of the cases. Radiographic findings are 
similar to the classic OS. There is a rare association with Rothmund-Thompson syndrome [14].  
OS complicating Paget’s is rare but well recognized with incidence of 0.95%. Paget’s related OS 
primarily affect males in the seventh decade of life (Figure 8-11). The distribution of lesions is 
similar to that expected with uncomplicated Paget’s disease. The sites most commonly affected 
sites are the pelvis, femur and humerus. The bones of the pelvis are most commonly involved; 
the humerus and the femur are next in frequency. No region of the skeleton is spared, with the 
exception of the forearms and hands. In 30 per cent of cases, these neoplasms are multifocal. 
The tumors are categorized radiographically as lytic, mixed, and sclerotic, in descending order 
of frequency. Diagnosis on plain radiographs may be quite difficult because of the underlying 
Paget’s changes and osteolyic lesions that sometimes occur in Paget's disease. Histologically 
these tumors are typically highly polymorphic sarcomas. The prognosis is poor with only 3%-
8% of patients surviving at five years. The main cause of death is pulmonary metastasis or 
local extension of tumor growth. A high index of suspicion should be maintained when 
evaluating radiographs of patients with Paget disease, especially of those who present with 
pain or a palpable mass [21, 22 & 23].  
 
Fig. 8. Two images of the mid shaft of the femur that shows a pathological fracture. The 
fracture occurred in a Pagetic bone. Note the heavy periosteal reaction at the fracture site 
(arrows). The initial diagnosis was periosteal new bone formation around a fracture site. 
However, a biopsy was taken that revealed a sarcomatous transformation of Paget’s disease. 
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Fig. 9. Radiograph of a pelvis shows considerable sclerosis and coarsening of the trabecular 
pattern suggestive of Paget’s disease. The diagnosis of Paget’s disease was confirmed on 
previous imaging and blood biochemistry 10 years earlier. The patient had bone pain for 
some time but had recently worsened and had become more focal to the left hip. Note 
bilateral Paget’s coxopathy and much more prominent sclerosis admixed with lysis in the 
left iliac bone. There is a soft tissue component superior to the left hip. Because of the 
atypical symptoms a radiographic changes a biopsy was taken. The biopsy confirmed 
sarcomatous transformation of Paget’s disease. 
There is a rare association of OS and a bone infarct. Imaging diagnosis may be difficult with 
such a relationship as changes seen suggest benign characteristics of a bone infarct. Diagnosis 
only become apparent with advanced OS. In a review of 50 cases of infarct associated OS, a 
disproportionate number of patients were black. In most patients, there was no known cause 
for the infarct, whereas in the remainder, the most common underlying disease was a earlier 
dysbaric event or alcoholism. Approximately 75% of the patients had multiple bone infarcts. 
Most infarct associated OS involved the femur, tibia, humerus and the radius in that border of 
frequency. The survival rate in patients with infarct-associated OS is poor [24, 25].  
The main limitations of plain radiography in OS are underestimation of the tumor's extent 
within and outside of the bone and other bone lesions, such as Ewing sarcoma, 
chondrosarcoma, and fibrosarcoma, infections or Langerhans cell histiocytosis may 
resemble OS on plain radiographs [26]. 
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Fig. 10. Non-contrast CT scans performed on the skull of a 70-year old female known to 
have Paget’s disease. The patient had recently presented with increasingly severe occipital 
headaches. The scans show dense sclerosis at the base of the skull in keeping with Paget’s 
disease. Note the area of bone destruction of the occiput (arrow).  The CT scans show the 
usefulness of the technique in the presence complex bone structure. A biopsy taken from the 
occipital bone revealed a sarcomatous transformation of Paget’s disease. 
 
Fig. 11. MRI scans on the same patient as in Figure 10 depicted in T1W and Gadolinium 
enhanced axial, coronal and sagittal images. The images show an enhancing occipital skull 
diploic mass that is sparing the brain (see Figures 10).  
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4. Magnetic resonance imaging 
MRI is the modality of choice in the evaluation of focal benign and malignant bone lesions. 
MRI has excellent capabilities in the local staging of malignant tumors because of its good 
bone marrow and soft tissue contrast and multiplanar facility. As calcium returns no signal, 
MRI is insensitive to small foci of calcification. Not only does MRI makes a significant 
contribution to correct local staging of OS it also assists in determining the most appropriate 
surgical management. The most fundamental purposes of local staging, is the assessment of 
tumor relationship of the anatomic domain from which it originates. MRI fulfills this job 
exceptionally well and defines individual bones, joints, and surrounding fascia and 
neurovascular bundles elegantly. Ultimate prognosis of OS depends on the number of 
compartments involved (Figures 13, 14 & 21-23, 25-26, 28) [27, 28, 29, 30 & 31]. 
 
 
 
 
 
 
 
Fig. 12. Thumb and hand radiographs from the departmental archives of two unrelated 
patients. Patent A had suffered from a solitary enchondroma of the first metacarpal bone for 
some time. The radiograph shows an expansile lytic lesion in the first metacarpal bone. A 
histological diagnosis of OS was made. Image B is from a patient that had worked with 
radium watch dials 20 years earlier. The image shows a biopsy proved OS of the first 
metacarpal bone. Note the mixed lytic/sclerotic lesion of the first metacarpal bone, also note 
the periosteal reaction and surrounding soft tissue swelling. 
www.intechopen.com
 Imaging Osteosarcoma 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. AP and lateral radiographs of the lower femur of 76 year old man that had suffered 
from chronic osteomyelitis for some years. The patient recently presented with a change in 
the pattern of symptoms. The images show destruction of the lower femur associated with 
periosteal new bone formation. Some of the destroyed bone is well corticated indicative of a 
chronic process. Initial diagnosis was that of recrudesce of osteomyelitis. The patient was 
treated accordingly despite a negative aspiration. A repeat radiograph (see next image) 
show worsening “sun ray” periosteal that prompted a biopsy, which showed OS 
complicating chronic osteomyelitis. 
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Fig. 14. AP and lateral radiographs of the lower femur of 76 year old man that had suffered 
from chronic osteomyelitis for some years. The patient recently presented with a change in 
the pattern of symptoms. The images show destruction of the lower femur associated with 
periosteal new bone formation. Some of the destroyed bone is well corticated indicative of a 
chronic process. Initial diagnosis was that of recrudesce of osteomyelitis. The patient was 
treated accordingly despite a negative aspiration. A repeat radiograph (see previous image) 
show worsening “sun ray” periosteal that prompted a biopsy, which showed OS 
complicating chronic osteomyelitis (also see Figure 13). 
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Fig. 15. An AP radiograph of pelvis from a patient with known multiple hereditary 
exostoses that presented with a 3 month history of increasing right buttock pain. There is a 
mixed lytic/osteosclerotic lesion in the right iliac bone adjacent to the right sacroiliac joint. 
A biopsy was taken, which showed a sarcomatous degeneration. An exostosis is noted 
arising from the region of the left anterior super iliac spine.  
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Fig. 16. Series of images from a patient with a long and family history of multiple hereditary 
exostoses are shown above. The patient presented with increasing pain over the left greater 
trochanter. An exostosis of the left greater trochanter was recorded 4 years earlier on 
radiograph taken prior to a right hip replacement. Image B is from an un-enhanced axial CT 
through the trochanter. The section shows calcification overlying the left greater trochanter 
associated with overlying prominent soft tissues. This finding by itself does not represent a 
malignant change. Images C and D show technetium-99m (99m Tc) methylene 
diphosphonate scans. The MDP scans show intense activity in the region of the left greater 
trochanter and L1/L2 vertebral bodies. A biopsy taken from the greater trochanter 
confirmed OS. The activity in L1/L2 were subsequently proved secondary to osteoporotic 
fractures. 
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Fig. 17. Imaging studies may be sometimes confusing. Purely osteolytic osteosarcoma may 
mimic malignant fibrous histiocytoma, fibrosarcoma or giant cell tumours. Osteosarcoma 
with diaphyseal location may suggest Ewing's sarcoma or lymphoma. Occasionally 
traumatic periostitis/traumatic myositis ossificance may resemble OS as in this case. 
www.intechopen.com
 Osteosarcoma 58
 
Fig. 18. A radiograph of the left knee of a 65-year old man is shown. The radiographic 
appearances are characteristically those of an OS. Figures 19-26 are images from the same 
patient showing the value of various modalities. 
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Fig. 19. A chest radiograph of the patient from figure 18 showing calcified cannon ball lung 
metastases.  
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Fig. 20. A technetium-99m (99m Tc) methylene diphosphonate scan was performed on the 
same patient as in Figure 18 to look for other bone lesions. Activity is seen in the left lower 
femur associated intense hyperemic peritumoral isotope uptake.    
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Fig. 21. Unenhanced CT scan through the upper left femur, which shows a break in the 
cortex (arrow) associated with cortical thinning and effacement of intramedullarly bone 
marrow. The described observations are at a much higher level than depicted by 
radiography and the MDP scan. It is difficult to be certain as to whether these findings are 
related to reactive bone changes or a skip lesion as no biopsy was taken from this focus. 
Nevertheless the CT scan demonstrate its potential. 
 
Fig. 22. Axial CT scans (the same patient as in Figure 18) through the lower left femoral tumor 
showing a mixture of osteosclerotic and lytic changes associated with ‘sun ray’ periosteal new 
bone formation. Also, seen are surrounding muscle and subcutaneous edema. 
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Fig. 23. Axial CT scans (the same patient as in Figure 18) through the lower left femoral 
tumor showing a mixture of osteosclerotic and lytic changes associated with ‘sun ray’ 
periosteal new bone formation. The images are interpreted on a soft tissue window. The 
images show growth of the tumor into the knee joint (arrow). 
 
Fig. 24. Axial CT scans (same patient as in Figure 18) through the lungs interrogated on a 
bone window showing lung metastases. The lesion in the left costophrenic angle (image B) 
is calcified/ossified.  
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Fig. 25. Axial T1W MRI scans through the tumor (same patient as in Figure 18) showing low 
signal osteosclerotic bone lesion.   
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Fig. 26. STIR sequence coronal images (same patient as in Figure 18) show the extent of the 
tumor and tissue edema.   
 
Fig. 27. Two images from technetium-99m (99m Tc) methylene diphosphonate bone scans 
are shown to demonstrate the importance of this technique in the diagnosis of OS. Image A 
show a skip lesion in OS (arrow). Image B shows extensive bony metastases from OS. 
www.intechopen.com
 Imaging Osteosarcoma 65 
 
Fig. 28. A chest radiograph of a 13 year old boy showing a destructive lesion of the 
metaphysis and upper third of the shaft of the right humerus. The image shows a 
permeative lesion with surrounding periosteal reaction (red arrow) and a Codman triangle 
(yellow arrow). The child presented with pain in his right shoulder following minor trauma. 
Image B shows a longitudinal ultrasound examination of the right humerus. The image 
shows the tumor itself (T) periosteal new bone formation (white arrow) edema surrounding 
the tumor (green arrow) and a hole in the cortex (interrupted arrows). The areas pinpointed 
by the interrupted arrows would lend itself to a guided biopsy. 
When assessing solitary bone lesions either a T1-weighted or a short-tau inversion recovery 
(STIR) sequence should be performed to include the entire bone.  
The inclusion of the whole length of the bone is necessary to image skip lesions and evaluate 
the longitudinal distance of the tumor. The epiphysis is also included. Accurate assessment 
of the extent of intraosseous and extra osseous extension of the tumor is a crucial parameter 
that will ultimately affect the treatment and prognosis. Periosteal OS is of chondroblastic 
origin and present with high signal on T2W MRI [29, 32]. 
Histological opinion is required in suspected OS. Biopsy should be performed following 
MRI evaluation as hemorrhage occurring at the biopsy site alters the signal intensity 
characteristics of the tumor at subsequent MRI examinations [28]. 
T1W spin-echo MR images provide the most accurate estimate of the longitudinal extent of 
the tumor. STIR sequence overestimates the extent of the tumor because of edema and 
marrow hyperplasia, which may show signal changes similar to the tumor. It is necessary to 
determine the maximum longitudinal extent of the tumor, and its maximal distance from 
the articular surface of the nearest joint. 
Epiphyseal tumor growth is associated with signal changes within the epiphysis similar to 
the tumor and may be seen in association with focal destruction of the growth plate. Both 
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STIR and T1-weighted sequences are correct in the diagnosis of epiphyseal tumor growth, 
and although T1W MR is more specific, STIR sequence images are slightly more sensitive. 
 
Fig. 29. An MDP bone scan on the same child as in Figure 28 shows a single lesion right 
humerus (arrow) B is a magnified of A. Note that the metaphysis is relatively photon 
deficient. Excessive osteoclastic activity may explain the reduced isotope uptake in the 
upper humerus. 
Skip lesions associated with OS are foci of tumor quite distinct and at a distance from the 
primary tumor represent metastases. Tumor deposits across a joint but on the ipsilateral side 
are termed transarticular skip metastases. Patients with skip lesions have a more guarded 
prognosis and are more likely to have distant metastatic disease and shorter periods of 
disease-free survival. 
The extent of extraosseous tumor element and its relationship to the muscle compartment 
and the neurovascular bundles and adjacent joints is well depicted on STIR and fat-
suppressed, T2-weighted or proton density–weighted sequences. The neurovascular bundle 
is regarded as disease free when an intervening plane of muscle or fat is seen separating the 
tumor from the neurovascular bundle. When the tissue plane between the tumor and the 
neurovascular bundle is abolished, disease extension is presumed. Tumor extension to a 
joint is assumed when tumor tissue is seen within the joint breaching the subarticular bone 
and cartilage. Tumor infiltration along the cruciate ligaments is regarded diagnostic of 
tumor extension into the knee joint. MRI is more accurate in identifying tumor growth to the 
cruciate ligaments than to the intrasynovial joint space. 
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Fig. 30. This 12-year old boy presented with a painful swelling of the left upper thigh. A 
radiograph of the left, upper femur shows an aggressive bone lesion. There is destruction 
the femoral metaphysis and upper two third of the shaft of the femur. Note the exuberant 
periosteal ‘sun ray’ periosteal reaction (red arrow) and A Codman triangle (yellow arrow). 
Image B is an MDP scan showing intense activity at the tumor site. 
Four patients with progressive pain associated with Paget’s disease were evaluated with 
MRI. Conventional radiographs showed diffuse progressive osteolysis, cortical resorption, 
insufficiency fractures, bowing, and cortical and trabecular thickening. MRI showed 
preservation of fatty marrow signal in all phases of Paget's disease except in patients with 
an acute fracture and sarcoma. Small focal linear or oval areas of low signal were seen 
against a background of normal marrow signal on short or long TR/TE, which did not 
resemble a tumor. The findings suggest that unless an acute fracture or tumor is present 
fatty marrow signal is preserved in advanced Paget's disease [33]. 
MRI to confirm or exclude a sarcoma evaluated five symptomatic patients with Paget’s 
disease. Two patients whose MRI showed a low signal' abnormality on the T1-weighted 
sequence corresponding to osteolysis on the radiograph were found to have malignant 
degeneration. Three patients with preservation of fat signal in areas of osteolysis were not 
biopsied and ultimately prove benign. In symptomatic patients, with Paget’s disease with 
osteolysis but preserved marrow signal on T1-weighted MRI may be used in the basic 
decision-making process between conservative follow-up and biopsy [34]. 
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Dynamic gadolinium contrast-enhanced MRI (DCE MRI) has been evaluated in a number of 
areas in the management of OS. The use of DCE MRI provides useful information as the 
characteristics of the enhancement pattern differ in viable tumor. DCE MRI has been found 
useful in high lighting the most appropriate location for a tissue biopsy. DCE MRI is useful 
in detecting joint involvement. Although MRI is highly sensitive for detecting joint invasion, 
false-positive diagnoses may lead to over staging of tumor and result in unnecessarily 
radical surgical procedures [35]. 'High signal' intensity on T2W MRI is not reliable in 
predicting the Grade of parosteal OS. Contrast enhanced T1-weighted images can be 
valuable to show the solid component in the heterogeneous areas on T2-weighted images, 
and can be useful in guiding a biopsy [36]. 
Gd-enhanced MR imaging could assist in obtaining diagnostic biopsy material of 
chondroblastic OS by identifying both osteoid and chondroid forming tissues. Geirnaerdt 
MJ et al found that septonodular and peripheral rim enhancement represented tumor with a 
pure chondroid matrix, whilst non-enhancing and heterogeneous enhancing areas 
represented tumor with both chondroid and osteoid matrix [36, 37]. 
Yakushiji et al found diffusion weighted MRI (DWI) more reliable than DCE MRI in 
differentiating between chondroblastic osteosarcoma and chondrosarcoma or other types of 
osteosarcoma [38].  
In order to detect differences in MRI between chondroblastic osteosarcomas (CO) and the 
other types of osteosarcomas or chondrosarcomas (CS) using gadolinium-enhanced versus 
diffusion-weighted sequences Yakushiji T et al recruited 5 CO, 17 other types of OS and 18 
CS.  Both CO and CS showed a similar enhancement pattern; both showed septonodular 
and peripheral rim enhancement. The authors found DWI more useful for differentiating 
between CO, OS and CS or other types of osteosarcoma than Gd-enhanced MRI [38]. 
MRI can evaluate treatment response to chemotherapy. Oka et al evaluated the role of 
Diffusion-weighted MRI in 22 patients with OS, before and after chemotherapy, using the 
average and minimum apparent diffusion coefficient (ADC). The authors found the 
minimum ADC a better tool than the average apparent diffusion coefficient ADC for 
evaluating the chemotherapeutic response of patients with osteosarcoma. Conventional and 
diffusion-weighted MRI can predict chemotherapeutic response of OS early in the disease 
course, and it correlates well with necrosis. In addition, newly derived parameter diffusion 
per unit volume appears to be a sensitive substitute for response evaluation in OS [39, 40]. 
Gadolinium based contrast has been linked to nephrogenic systemic fibrosis. The use of 
contrast requires intravenous access and adds extra cost and time to the procedure. 
Although it may have a role in the staging of OS, its use is not universally accepted and 
many centers do not currently consider it a standard part of the staging protocol. 
5. Computed tomography 
CT and MRI are the imaging procedures of choice in locoregional staging as either modality 
depicts intraosseous and extraosseous spread, skip metastases, growth plate and articular 
involvement. Thoracic CT is the study of choice in detecting lung metastases [26, 41]. 
CT is particularly advantageous in clarifying OS is areas with difficult bone structure, such 
as the maxilla, mandible or pelvis where inconsistent images are seen by conventional 
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radiography. In this setting, CT scans provide a clearer picture of regional anatomy, bone 
destruction, as well as the extent of soft tissue mass, the nature and extent of parosteal, 
periosteal, and surface high-grade OS. 
CT scanning may render small amounts of mineralized osseous matrix not seen on 
radiographs and thus alter the differential diagnosis. CT is especially useful, in visualizing 
flat bones where periosteal changes may be more difficult to recognize. 
CT is useful in the evaluation of some OS variants. Telangiectatic osteosarcoma may be 
confused with an aneurysmal bone cyst especially when associated with fluid/fluid levels. 
A contrast-enhanced CT scan can be useful in discriminating such a lesion from an 
aneurysmal bone cyst. Telangiectatic OS is often associated with dense nodular tissue and 
matrix mineralization at CT in a largely hemorrhagic and/or necrotic osseous lesion with an 
associated soft-tissue mass, a feature that allows differentiation from aneurysmal bone cyst 
[42]. The nodular tissue surrounding telangiectatic OS is made up of tumor cells that 
surround the cystic spaces. This tissue rim shows typically nodular enhancement after the 
intravenous administration of contrast material. 
Periosteal OS and high-grade surface OS may have similar plain film findings. However, 
histologic and radiological findings are considered together to provide a definitive 
diagnosis. Prognosis is dictated by tumor size and histologic grade. CT and MRI are more 
accurate than other imaging for preoperative diagnosis of tumor extent and for assessing 
tumor relationships to the bone cortex and medullary cavity (Figures 21-26) [43].  
A CT guided needle biopsy is a safe and effective technique that is pertinent in the diagnosis 
and management of musculoskeletal tumours [44, 45]. 
CT ideally investigates the exclusion of metastatic OS. Lung nodules discovered on CT are 
biopsied or resected. Solitary nodules represent pseudometastasis in about 25% of cases 
[46]. Pseudo-metastases should always be confirmed in patients with OS. Some advocate 
that even if the nodules disappear following chemotherapy, the patient should undergo a 
thoracotomy. Small foci of residual cancer may occur, and they will most probably 
reappear in the original CT-positive areas if the patients do not have a thoracotomy and 
removal of nodules. Calcified/ossified tumors within the lungs have a broad differential 
diagnosis (see Table 1). 
6. Nuclear medicine 
OS typically show increased uptake of radioisotope on bone scans obtained by use of 
technetium-99m (99m Tc) methylene diphosphonate (MDP). The uptake is dependent on the 
amount of osteoblastic activity within the tumor. The bone uptake is often more than the 
extent of the tumor due to reactive response surrounding the tumor. The size of the tumor is 
therefore, difficult to assess on bone scans. Skip lesions and pulmonary metastases may also 
pick up the radioisotope, but skip lesions are more reliably depicted by MRI. Bone scans are 
most useful in excluding multifocal disease. The sensitivity of bone scans in the diagnosis of 
OS is high, but specificity, is low as a multitude of bone lesions show increased isotope 
uptake including trauma, metabolic bone disease, tumors and infections (Figure 27, 29-30).  
Multiple-gated acquisition (MUGA) cardiac scans are often required to monitor the harmful 
effects of certain chemotherapy, and a baseline line scan is often obtained. 
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(99m)Tc-MIBI scintigraphy can be used to assess response to chemotherapy in OS. 
(99m)Tc-MIBI scintigraphy has been compared with (201) Tl scintigraphy, angiography, 
and conclusions drawn that it could effectively predict the final response to chemotherapy 
of OS [47].  
Increased Tc-99m MDP uptake has been reported in sarcomatous degeneration in a patient 
with Paget's disease. As expected Tc-99m MDP imaging showed abnormal uptake in both 
Paget’s and the sarcomatous change. However, Tl-201 imaging showed increased uptake in 
the sarcomatous lesion only. The finding supports the idea that Tl-201 scintigraphy may 
have a potential role to play in the differentiation of Paget's disease from malignancy [48]. 
Positron emission tomography (PET) provides physiological understanding of both normal 
and abnormal body tissues. PET scanning uses a wide range of radiotracers some tissue 
specific. The most widely used radiotracer is an analogue of glucose specifically F-18 fluoro-
2-deoxy-D-glucose (FDG). FDG uptake in body tissues is equivalent to the intensity of 
glucose metabolism, which increases many folds in malignant tissue. FDG-PET has become 
the criterion standard in initial staging, monitoring therapeutic response in the management 
of various cancers. However, the lack of anatomical information has resulted in the complex 
fusion imaging with CT. Thus, PET-CT not only provides physiological information, but 
also structural information leading to the diagnosis of sub-centimetre lesions. The detection 
of smaller lesions has made the procedure useful in the early diagnosis of the disease 
process and decreasing false-positive lesions [49]. Positron emission tomography imaging is 
a powerful emerging imaging technique in the management of sarcomas. Its applications 
include tumor grading, staging, therapy monitoring, and prognostication in both adult and 
pediatric populations [50]. The degree of tumor necrosis is indicative of progression-free 
survival, overall survival, and tumor necrosis in OS where (18) F-FDG PET/CT can be used 
as a prognostic indicator [51]. FDG-PET scanning depicts significant additional information 
in staging of pediatric sarcoma, which has a relevant impact on treatment planning when 
compared with other conventional imaging modalities [52]. FDG-PET/CT has a 
complementary role in the establishment of local recurrence and distant metastases in 
pediatric sarcomas [53]. 
The long-term survival with bone sarcomas is closely linked to the response to pre-operative 
chemotherapy. Response to chemotherapy is assessed in a variety of ways: Clinically, by 
demonstrating a reduction in pain and swelling of the affected limb. Imaging features of a 
positive response are a reduction in tumor vascularity and edema on CT or MRI. 
Conventional radiography is not a reliable indicator of increased vascularity or edema. 
However, radiologic findings have limitations. The actual size of OS show no change after 
chemotherapy, and it is difficult to estimate bone response objectively. Therefore, 
responders can be difficult to distinguish from non-responders by CT or MRI. The histologic 
response is considered the most reliable prognostic indicator for survival of patients with 
OS. However, the histologic response can only be obtained after surgery, which might not 
always be available in inoperable tumors. FDG-PET can be used as a non-invasive surrogate 
to predict response to chemotherapy in children with bone tumors [54]. 
7. Ultrasound  
Presently there are no advantages of ultrasound over other imaging techniques and 
ultrasound has not been widely accepted in the diagnosis of OS, but there are certain 
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exceptions where US excels. The US features of bone neoplasia include bone destruction, 
elevated periosteum and a soft tissue mass. Giant cell tumors, malignant bone tumors, bone 
cysts, as well as metastatic lesions, have differing sonographic features with one study 
showing that sonography has equally high accuracy in the diagnosis of these tumors 
compared with conventional radiography (Figure 28 & 31) [55]. 
 
Fig. 31. Ultrasound images of the femur of the same patient as in Figure 33. Note the 
periosteal reaction (A & B) and a soft tissue window, which can be used for obtaining tissue 
for biopsy purposes.   
Ultrasound features of an OS of the mandible have been described in a young adult. The 
patient presented with a facial swelling, and an infected lower third molar tooth that was 
extracted. Subtle signs were missed on dental radiographs. However, an ultrasound 
examination was crucial in identifying signs of malignancy including a soft tissue mass 
associated with bone thinning, erosion, expansion, and the "sunray" appearance of the 
buccal cortex, which were reminiscent of OS. Subsequently other imaging confirmed these 
findings [56]. 
Wild et al studied five patients with histologically confirmed OS by US and colour Doppler 
US. The features included a large soft tissue tumor with echogenic osteosclerotic areas and 
echo-free caverns within the tumor. Cortical destruction and periosteal elevations were well 
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depicted. Compared to normal tissue there was increased vascularity associated with 
increased blood flow in colour coded Doppler sonography in the region of the tumor. 
Sonography and colour coded Doppler sonography are valuable additions of conventional 
radiology to describe the structure, growth and blood supply of an OS [57]. 
Lau et al described a parosteal OS that presented 20 years following initial diagnosis, that 
was treated with wide excision and mega-prosthesis to reconstruct the femur. The tumor 
recurred in proximity to the femur prosthesis and encased half the femoral stem. Because of 
a metal prosthesis at the site of recurrence, US was used to detect the lesion. The tumor was 
eventually treated successfully, with extensive local re-excision. The case emphasise the 
importance of long-term follow up of parosteal sarcomas and the role of US in the presence 
of metal prosthesis [58]. 
Ultrasound is an invaluable skill for guided biopsies. OSs that have broken through the 
cortex into the soft tissues is receptive to US guided biopsy. Saifuddin and associates have 
assessed the diagnostic accuracy of US-guided Trucut needle biopsy in patients with 
suspected primary bone tumors. Of 144 patients, 63 were considered suitable for US-guided 
biopsy. The results of needle biopsy were compared with those of surgical biopsy. The 
diagnostic accuracy was 98.4%, with only a single failed biopsy. The authors regard US as a 
highly reliable method of guidance for percutaneous needle biopsy of bone tumors [59].  
US can effectively evaluate the extra-osseous component of malignant and aggressive 
benign bone tumors arising from bone surfaces. Periosteal reaction, cortical destruction, 
pathological fractures, matrix mineralization, fluid-fluid levels and involvement of the 
neurovascular bundle are readily detected. However, ultrasound was found to be of 
immense help in guiding percutaneous needle biopsy [60]. 
Ahrar et al took, image guided biopsies on 33 patients with 35 bone lesions suspicious for 
OS. Of those 35 biopsies, 12 were performed fluoroscopical or with CT guidance. In 23 
patients, MRI revealed a soft tissue component; in these cases, biopsies were US guided to 
target the soft tissue component of the tumor. All 23 US-guided biopsies resulted in positive 
diagnosis. Two of the 12 fluoroscopy- or CT-guided biopsies (17%) were inconclusive [61].  
Soft tissue recurrence of OS may follow limb salvage surgery, and insertion of a metallic 
endoprosthesis, which is well depicted by US and lends itself to US guided biopsy [62]. 
Ultrasound has been invaluable in predicting response of OSs to chemotherapy. van der 
Woude et al have studied the efficacy of sequential color Doppler sonography in predicting 
histopathologic response to neoadjuant chemotherapy of high-grade bone sarcomas. They 
concluded that a decreased or unaltered resistive index in the arteries that feed tumors, in 
addition to continuing, intratumoral flow and high-frequency Doppler shifts after two 
cycles of chemotherapy suggested a poor histologic response whilst an increased resistive 
index after two cycles is indicative of significant response [62]. Bramer et al used Color 
Doppler US in pediatric osteosarcoma and found that it can predict chemotherapy response, 
but not survival. The method could be useful in planning treatment prior to definitive 
surgery [63]. 
High-intensity focused ultrasound has been used in tumor ablation. Chen et al have 
evaluated US-guided high-intensity focused ultrasound ablation of malignant bone tumors 
and found it feasible and effective, and have suggested that eventually it may become a part 
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of limb-sparing techniques. Chen et al also concluded that sonographically guided high-
intensity focused ultrasound ablation was a safe and practical method of treatment of 
osteosarcoma which salvages the limb, but large-scale randomized clinical trials are needed 
for confirmation [64, 65]. 
8. Radiological intervention to assist tissue diagnosis 
Biopsy is always required in a suspected OS as there is a comprehensive clinical and imaging 
differential more over histology prognosticate the tumor. Orthopedic surgeons choose an open 
biopsy. However, a large core needle image guided biopsy may suffice. Recently, a fine needle 
aspirate (FNA) for cytological investigation has been advocated, but there is a margin of error 
in the interpretation of FNA as under-diagnosis or incorrect diagnosis may occur. The 
accuracy of FNA in primary malignant bone tumors is 86.9%, and specificity a 100%, and 
cytological categorization of tumors is possible in the majority of cases. This eliminates the 
need for bioptic confirmation [66, 67]. Material from FNA may provide additional information 
from electron microscopy, immunocytochemistry, cytochemistry, DNA-ploidy analysis, 
chromosomal analysis and molecular genetics [68]. The biopsy tract should be placed where 
the tract could be excised. Kilpatrick et al reviewed the clinicopathologic features of 145 FNA 
biopsy specimens from 140 patients without a previous diagnosis of sarcoma. Most FNA 
specimens are easily recognized as sarcoma, but subtyping is more accurate in bone sarcomas. 
Histologic subtyping of adult soft tissue sarcomas is often difficult, but this fact by itself has no 
impact on initial therapy. In contrast, subtyping of pediatric sarcomas by FNA seems most 
accurate and is essential for proper therapy [69]. 
Altuntas et al retrospectively studied CT guided core biopsies in a series of 127 patients with 
musculoskeletal tumors. The accuracy of the CT-guided core needle biopsy was determined 
by comparing the histology of the biopsy with the final histology of the specimen obtained at 
open biopsy or surgical resection of the tumor. The effective accuracy was determined, by the 
accuracy of the biopsy to distinguish between a benign and malignant tumor. The overall 
accuracy of CT guided core needle biopsy was 80.3%. The effective accuracy as determined by 
a malignant versus benign lesion was 89%. CT guided core needle biopsy was considered a 
safe and effective approach to obtain material from musculoskeletal tumors including OS [70].  
Histologically differential diagnosis of OS is not immune to erroneous interpretation, as OS 
may have to be distinguished from a malignant fibrous histiocytoma or a poorly 
differentiated fibrosarcoma. Rarely an OS may histologically resemble a soft tissue sarcoma 
or an aneurysmal bone cyst. Therefore, when interpreting histology of bone tumors clinical 
and radiological correlation is vital [71, 72]. 
Yang et al retrospectively reviewed data from 508 image-guided needle biopsies of patients 
with suspected musculoskeletal tumors to determine factors leading to non-diagnostic 
results. The interpretations of 89% needle biopsies were correct and clinically useful. Nine 
per cent were non-diagnostic, and 2% were wrong. Bone lesions had a higher non-diagnostic 
rate than soft tissue lesions (13% vs. 4%). Rare subtypes of OS had higher incorrect rates 
than other diagnoses. Repeat needle or open biopsies were performed in 14% patients. Bone 
lesions were more likely than soft tissue lesions to require repeat biopsies. The authors 
concluded that a high rate of accuracy and clinical usefulness are possible with image-
guided needle biopsies of musculoskeletal lesions with an experienced musculoskeletal 
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tumor team with regular communication to correlate clinical, radiographic, and histologic 
data for each patient [73]. 
Careful planning of the biopsy site and track must be undertaken to prevent contaminating 
the soft tissues that the surgeon would not otherwise remove. The biopsy track is usually 
resected at surgery. If delay is anticipated between biopsy and surgery, the track may be 
marked with suture, to facilitate eventual safe surgical resection. 
9. Angiography 
Angiographic findings associated with OSs include neovascularity and hypervascularity, 
tumor staining, early venous drainage, arterial displacement, and arterial diameter changes. 
Tumor staining is most familiar with osteolytic OS. These angiographic findings are not 
specific as similar changes occur in other malignant bone tumors. These angiographic 
findings are not usually seen with benign tumors with an exception of an occasional arterial 
displacement. The extra-skeletal part of OS is better depicted by angiography, which is not 
clearly seen on conventional radiography. Usually, the extra-skeletal part of OS is larger 
than that in giant cell tumor [74]. During the last three decades, the development of CT and 
MRI has determined that conventional angiography no longer be routinely performed in the 
diagnosis of OSs. Conventional angiography, however, is useful as an adjunct to the biopsy 
of parosteal OS [75]. Occasionaly tumor and vessel relationship may sometimes be better 
depicted angiography than by CT.  Hudson and associates found angiography useful in 
planning non-ablative resection of bone tumors because they demonstrated the relationships 
of the tumors to main vessels. Experience with CT indicates that it can accurately describe 
intra-osseous and soft-tissue extent of bone tumors. If CT does not accurately assess vascular 
relationships, angiography may still be required. Angiography may sometimes also assist in 
anticipating operative blood loss, demonstrating variants of vascular anatomy, or 
organization biopsy [76]. Sellier N and associates studied retrospectively 32 children with 
malignant bone tumors. All patients underwent conventional arteriography just before 
surgery. Angiography depicted distal foci of hypervascularity and venous thrombosis, not 
seen at CT. These findings may vary surgical treatment. Arteriography provides 
unparalleled characterization of large soft extension of the tumor and remains unchallenged 
in the assessment of venous involvement [77]. 
Angiography is an integral part of intra-arterial chemotherapy and embolization before limb 
salvage surgery in patients with OS of the lower extremity. Zhang HJ et al studied 47 
patients that underwent Intra-arterial chemotherapy and embolization 3-7 days 
preoperatively to evaluate the effectiveness of this procedure on the degree of tumor 
necrosis and on the amount of blood loss during surgery. Limb salvage was achieved 
successfully in all cases. The percentage tumor necrosis induced by treatment ranged from 
70.2% to 94.2%. The estimated blood loss during surgery, from drains in the postoperative 
period, and transfusion volumes were significantly lower in the studied patients as 
compared to the 65 patients who underwent surgery without preoperative intra-arterial 
chemotherapy and embolization. There is a significant reduction in the mean operative time 
in the embolized, group when compared to the controls [78]. Angiography has been used to 
assess response to combined intravenous and intra-arterial neoadjuvant chemotherapy. 
Cullen JW et al evaluated serial arteriography to evaluate tumor response, predict necrosis, 
and titrate the duration of combined intravenous and intra-arterial neoadjuvant chemotherapy 
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in patients with histologically proven high-grade OS or malignant fibrohistiocytoma of bone. 
Serial arteriography was highly sensitive and accurately predicted good responses and 
individualized and modified, dose-intensified neoadjuvant protocol with an excellent 
histologic response rate with minimal complications (Figure 32) [79]. 
 
Fig. 32. A peripheral angiogram showing its importance in the management of OS. The 
angiogram shows intense vascularity in the tumor (arrow). The popliteal artery is displaced 
medially. These findings are suggestive of OS in the appropriate clinical setting but not specific. 
Imaging remains the corner stone of diagnosis, treatment and predicting prognosis in OSs. 
We have a high diagnostic armamentarium. Each imaging modality has its own indications 
and limitations. Most OSs are imaged initially by conventional radiographs followed by 
MRI and a biopsy, which may be image guided. CT, US, radionuclide imaging and 
angiography have advantages in areas and used if indicated. 
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Differential Diagnosis Calcified Lung Nodules 
 
Single Large 
Pulmonary hamartoma 
Calcified granuloma 
Primary lung cancer 
Carcinoid 
Intrathoracic sarcomas 
Metastases: Primary sarcomas such as osteogenic, chondrosarcoma, synovial sarcomas, 
giant cell tumor, malignant mesenchymoma and fibrosarcoma of the breast, papillary 
and mucinous adenocarcinomas, and occasionally metastases from a medullary 
carcinoma  
Calcifying fibrous pseudotumor 
Intralobar pulmonary sequestration 
 
Multiple Large Calcified Nodules 
Amyloidosis 
Hyalinizing granulomas 
Progressive massive fibrosis 
Metastatic pulmonary calcifications 
Miscellaneous non-neoplastic lung tumors 
Many rare non-neoplastic lesions of the lung may mimic lung calcified tumors; these 
include inflammatory pseudotumor (inflammatory myofibroblastic tumor), placental 
transmogrification of lung, alveolar microlithiasis and metastatic calcification.  
Carney triad 
 
Reference: Khan AN, Al-Jahdali HH, Allen CM, Irion KL, Al Ghanem S,  Koteyar SS. The 
calcified lung nodule: What does it mean? Ann Thorac Med [serial online] 2010 [cited 2010 Apr 
13];5:67-79.  
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